Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation

Archives of General Psychiatry

Volumn 59, Issue 4, 2002, Pages 347-354

  Daskalakis, Zafiris J ^a   Christensen, Bruce K ^a   Chen, Robert ^b   Fitzgerald, Paul B ^c   Zipursky, Robert B ^a   Kapur, Shitij ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOMEPROMAZINE; LOXAPINE; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN REGION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS CALLOSUM; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG EFFECT; ELECTROMYOGRAPHY; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; LATENT INHIBITION; MALE; MOTOR CORTEX; PATHOPHYSIOLOGY; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0036214026     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.59.4.347     Document Type: Article

References (70)

1. Dopamine, schizophrenia, mania, depression: Toward a unified hypothesis of cortico-striatal-pallido-thalamic function
2. Developmentally moderated expressions of the neuropathology underlying schizophrenia
3. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia
4. Sensory gating deficits in parents of schizophrenics
5. Effects of sound intensity on a midlatency evoked response to repeated auditory stimuli in schizophrenic and normal subjects
6. Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects: Human recordings, computer simulation, and an animal model
7. Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain
8. Cortical pathology a new generation of quantitative microscopic studies
9. Non-invasive magnetic stimulation of human motor cortex
10. Corticocortical inhibition in human motor cortex
11. The effect of lorazepam on the motor cortical excitability in man
12. Marsden CD Interhemispheric inhibition of the human motor cortex
13. Interaction between intracortical inhibition and facilitation in human motor cortex
14. A comparison of paired-pulsed facilitation of AMPA and NMDA receptor-mediated excitatory postsynaptic currents in the hippocampus
15. Magnetic brain stimulation: The silent period after the motor evoked potential
16. Spinal motor neuron excitability during the silent period after cortical stimulation
17. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction
18. Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans
19. Mechanism of the silent period following transcranial magnetic stimulation: Evidence from epidural recordings
20. An investigation of motor function in schizophrenia using transcranial magnetic stimulation of the motor cortex
21. Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia
22. Decreased motor inhibition in Tourette's disorder: Evidence from transcranial magnetic stimulation
23. Transcallosal inhibition and motor conduction studies in patients with schizophrenia using transcranial magnetic stimulation
24. The assessment and analysis of handedness: The Edinburgh inventory
25. The positive and negative syndrome scale (PANSS) for schizophrenia
26. Clinical research techniques in tardive dyskinesia
27. A rating scale for extrapyramidal side effects
28. A rating scale for drug-induced akathisia
29. The effect of current direction induced by transcranial magnetic stimulation on the corticospinal excitability in human brain
30. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: Evidence from transcranial magnetic stimulation
31. Intracortical inhibition and facilitation in different representations of the human motor cortex
32. Complete suppression of voluntary motor drive during the silent period after transcranial magnetic stimulation
33. Inhibition of human motor cortex by ethanol: A transcranial magnetic stimulation study
34. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease
35. Replication and extension of P50 findings in schizophrenia
36. Midlatency auditory evoked responses in schizophrenia
37. Sensory gating deficits in schizophrenia: New results
38. Replication of a P50 auditory gating deficit in Australian patients with schizophrenia
39. Effects of P50 temporal variability on sensory gating in schizophrenia
40. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects
41. P50 suppression in recent-onset schizophrenia: Clinical correlates and risperidone effects
42. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications
43. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients
44. Evidence for altered trisynaptic circuitry in schizophrenic hippocampus
45. Neuronal responses to magnetic stimulation reveal cortical reactivity and connectivity
46. Paired-pulse magnetic stimulation of the human motor cortex: Differences among I waves
47. On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects
48. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia
49. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans
50. Interactions between two different inhibitory systems in the human motor cortex
51. Electroencephalographic studies myoclonus
52. Physiologic analysis of the myoclonus of Alzheimer's disease
53. Human cerebral cortical responses to contralateral transcranial stimulation
54. Physiological studies in a patient with mirror movements and agenesis of the corpus callosum
55. Inhibitory and excitatory interhemispheric transfers between motor cortical areas in normal humans and patients with abnormalities of the corpus callosum
56. Topography of fibers in the human corpus callosum mediating interhemispheric inhibition between the motor cortices
57. Meta-analysis of corpus callosum size in schizophrenia
58. Commisurotomy studies in animals
59. Paulus W Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs
60. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
61. From the cover: Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
62. Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors
63. Motor system excitability in healthy children: Developmental aspects from transcranial magnetic stimulation
64. Effects of antiepileptic drugs on motor cortex excitability in humans: A transcranial magnetic stimulation study
65. Effects of phenytoin on cortical excitability in humans
66. The glutamate antagonist riluzole suppresses intracortical facilitation
67. Dextromethorphan decreases the excitability of the human motor cortex
68. Electrophysiological responses to transcranial magnetic stimulation in depression and schizophrenia